Neurosense Therapeutics Correlations

NRSN Stock

USD 0.86 0.07 7.53%

The current 90-days correlation between Neurosense Therapeutics and Neurobo Pharmaceuticals is 0.14 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurosense Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurosense Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Neurosense Therapeutics Correlation With Market

Average diversification

The correlation between Neurosense Therapeutics and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.

Moving together with Neurosense Stock

0.72	VALN	Valneva SE ADR	Pair Corr
0.79	ERNA	Eterna Therapeutics	Pair Corr
0.74	INKT	Mink Therapeutics	Pair Corr
0.62	MBIO	Mustang Bio	Pair Corr
0.67	AMGN	Amgen Inc	Pair Corr
0.66	APGE	Apogee Therapeutics,	Pair Corr
0.61	AVDL	Avadel Pharmaceuticals	Pair Corr

Moving against Neurosense Stock

0.75	DYAI	Dyadic International	Pair Corr
0.55	ESPR	Esperion Therapeutics	Pair Corr
0.55	BMY	Bristol Myers Squibb	Pair Corr
0.36	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.33	FLGC	Flora Growth Corp	Pair Corr
0.33	GILD	Gilead Sciences Sell-off Trend	Pair Corr
0.31	MNMD	Mind Medicine	Pair Corr
0.51	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	QNRX	REVB	HILS	NRBO	VRAX	NTRB	LGVN	RNXT	BWV	KPRX
QNRX		-0.24	-0.32	-0.3	-0.03	-0.27	0.57	0.15	-0.32	0.38	QNRX
REVB	-0.24		0.17	0.44	0.41	0.44	0.35	-0.72	-0.27	0.16	REVB
HILS	-0.32	0.17		0.75	0.64	-0.05	-0.03	-0.14	0.08	0.19	HILS
NRBO	-0.3	0.44	0.75		0.63	0.17	0.06	-0.47	-0.24	0.36	NRBO
VRAX	-0.03	0.41	0.64	0.63		-0.15	0.35	-0.22	-0.09	0.44	VRAX
NTRB	-0.27	0.44	-0.05	0.17	-0.15		-0.08	-0.72	-0.55	-0.08	NTRB
LGVN	0.57	0.35	-0.03	0.06	0.35	-0.08		-0.15	-0.23	0.47	LGVN
RNXT	0.15	-0.72	-0.14	-0.47	-0.22	-0.72	-0.15		0.57	-0.11	RNXT
BWV	-0.32	-0.27	0.08	-0.24	-0.09	-0.55	-0.23	0.57		-0.31	BWV
KPRX	0.38	0.16	0.19	0.36	0.44	-0.08	0.47	-0.11	-0.31		KPRX
	QNRX	REVB	HILS	NRBO	VRAX	NTRB	LGVN	RNXT	BWV	KPRX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NRBO	+ 0.75	HILS
VRAX	+ 0.64	HILS
VRAX	+ 0.63	NRBO
LGVN	+ 0.57	QNRX
BWV	+ 0.57	RNXT
KPRX	+ 0.47	LGVN

High negative correlations

RNXT	- 0.72	NTRB
RNXT	- 0.72	REVB
BWV	- 0.55	NTRB
RNXT	- 0.47	NRBO
BWV	- 0.32	QNRX
HILS	- 0.32	QNRX

Risk-Adjusted Indicators

There is a big difference between Neurosense Stock performing well and Neurosense Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Neurosense Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
QNRX	5.60	0.36	0.06	0.55	5.35	(8.47)	9.21	(9.59)	74.46
REVB	4.26	(1.13)	0.00	(0.66)	0.00	0.00	8.97	(7.84)	73.15
HILS	5.56	(0.61)	0.00	(1.65)	0.00	0.00	8.33	(7.89)	113.15
NRBO	3.10	(0.94)	0.00	(0.63)	0.00	0.00	6.76	(7.34)	24.34
VRAX	5.27	(0.41)	0.00	0.82	0.00	0.00	9.65	(11.20)	61.28
NTRB	4.48	(0.04)	0.00	0.07	5.32	(5.04)	10.79	(8.78)	39.62
LGVN	2.81	(0.09)	0.00	(0.26)	0.00	0.00	8.29	(5.31)	18.33
RNXT	3.88	0.39	0.07	1.65	4.28	(4.99)	8.89	(6.38)	40.06
BWV	3.18	(0.26)	0.06	0.05	2.98	(5.30)	4.26	(4.72)	68.28
KPRX	2.94	(0.10)	0.00	(0.23)	0.00	0.00	5.95	(5.41)	19.67

Neurosense Therapeutics Corporate Management

Sharon Vered	Global CMC	Profile
Diana Shtossel	Head Affairs	Profile
Or Eisenberg	Chief Officer	Profile
Nedira SalzmanFrenkel	Global Devel	Profile
Yael Barak	Head Compliance	Profile
Alon BenNoon	CEO CoFounder	Profile
Hagit Binder	VP Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC